3- Month Micro-dosing Tirzepatide
US$ 23.45
when retatrutide available 20mg Retatrutide - “Triple G” |
Description
Before GLP-1s became available, the obesity rate in the U.S
Gastroenterology 149 , 38997.e10 (2015)
Lets quickly break it down
Ask your clinician how timing, monitoring, sick-day plans, and alternatives apply to your health history
With TRIUMPH-4 (December 2025, 28.7% weight loss), TRIUMPH-1 (May 2026, 28.3% in 2,339 patients), and now TRANSCEND-T2D-1 (June 2026, the first diabetes-specific Phase 3 readout) all confirmed, this investigational medication is rapidly approaching regulatory review
